Can adverse cardiac events of the COVID-19 vaccine exacerbate preexisting diseases?
| Autor: | Razzaque MS; Professor of Pathology, Lake Erie College of Osteopathic Medicine, Erie, PA, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Expert review of anti-infective therapy [Expert Rev Anti Infect Ther] 2024 Apr; Vol. 22 (4), pp. 131-137. Date of Electronic Publication: 2024 Feb 02. |
| DOI: | 10.1080/14787210.2024.2311837 |
| Abstrakt: | Introduction: SARS-CoV-2 infection and COVID-19 vaccination can both lead to serious cardiac conditions such as myocarditis, arrhythmia, acute myocardial infarction, and coagulopathy. Further studies are needed to better understand the risks and benefits of COVID-19 vaccination, and to determine the best course of action for individuals with preexisting heart conditions. Areas Covered: The current knowledge and challenges in understanding vaccine-associated heart issues concerning the COVID-19 pandemic are briefly summarized, highlighting similar cardiac conditions caused by either SARS-CoV-2 infection or COVID-19 vaccination and the potential clinical impacts. Expert Opinion: The short-term risks of severe cardiovascular side effects following COVID-19 vaccination are relatively low. However, further studies are needed to determine whether adverse vaccination events outweigh the long-term benefits in specific groups of individuals. Since cardiac inflammation, blood pressure dysregulation, coagulopathy, acute myocardial infarction, or arrhythmia could be the consequences of either SARS-CoV-2 infection or COVID-19 vaccination, clinical questions should be asked whether the COVID-19 vaccine worsens the condition in persons with preexisting heart diseases. It is important to carefully assess the potential risks and benefits of COVID-19 vaccination, especially for individuals with preexisting heart conditions, and to continue monitoring and studying the long-term effects of vaccination on cardiovascular health. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|